Pelthos Therapeutics Inc
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Pelthos Therapeutics Inc
Pelthos Therapeutics Inc is a clinical-stage biotechnology company developing and commercializing novel, non-opioid, non-addictive therapeutics to alleviate pain. The initial clinical focus is to selectively target the sodium ion channel known as NaV1.7 for the treatment of various types of chronic, visceral pain, acute and chronic eye pain, and post-surgical nerve blocks. Its pipeline includes CC8464 for ISFN and EM and CT2000 for Acute and CHronic Eye Pain-Dry Eye Disease.
/ 
Others were interested in
Frequently asked questions
To buy Pelthos Therapeutics Inc stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Pelthos Therapeutics Inc by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Pelthos Therapeutics Inc is PTHS:xase. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Pelthos Therapeutics Inc has its primary listing on NYSE American. You can trade Pelthos Therapeutics Inc with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Pelthos Therapeutics Inc is available to trade on SaxoInvestor and SaxoTrader. You can buy shares directly and include Pelthos Therapeutics Inc as part of a broader investment portfolio.
Learn more about investing and trading in Saxo's education hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures—so you can make more informed decisions when considering shares like Pelthos Therapeutics Inc.